WAVE Life Sciences (WVE) Tops Q4 EPS by 8c

WAVE Life Sciences (NASDAQ: WVE) reported Q4 EPS of ($0.15), $0.08 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $29.06 million versus the consensus estimate of $19.86 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• Gogoro CFO retires, Jacky Lee named principal financial officer
• Needham Reiterates Buy Rating on Veeva Systems (VEEV)